MetaNovas Biotech
PrivateLast Round
Series A
Dec 2, 2024
Total Funding Raised
$10M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MetaNovas Biotech is a biotechnology company that provides an artificial intelligence-enabled discovery platform for developing ingredients and products for the cosmetics, nutraceutical, and pharmaceutical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MetaNovas Biotech Comparables
Compare MetaNovas Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Endeavor BioMedicines | 79% | |
| Rein Therapeutics | 76% | |
| BenevolentAI | 74% |
MetaNovas Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 2, 2024 | ||||
| Angel | Mar 31, 2022 |
Key People
Founding team and executive leadership
MetaNovas Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hillhouse Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
Developing AI-generated peptides for the European cosmetics market with LEHVOSS Personal Care.
- Apr 8, 2026
Partnered with LEHVOSS Personal Care for AI-generated peptides in Europe.
Recent news
Latest coverage and updates
- launchesSep 14, 2026
MetaNovas launched Orphic on Sep 14th '26.
MetaNovas Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access